Department of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy; Department of Clinical and Molecular Sciences (DISCLIMO), Università Politecnica delle Marche, Via Tronto 10/A, 60126 Ancona, Italy.
Department of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy.
Bone. 2020 Aug;137:115363. doi: 10.1016/j.bone.2020.115363. Epub 2020 Apr 13.
The punctual analysis of bone Extracellular Matrix (ECM) proteins represents a pivotal point for medical research in bone diseases like osteoporosis. Studies in this field, historically done to appreciate bone biology, were mainly conducted on animal samples and, up to today, only a few studies on protein detection in human bone are present. The challenges in bone ECM protein extraction and quantitation protocols are related to both the separation of proteins from the mineral content (i.e. hydroxyapatite) and the difficulty of avoiding protein denaturation during the extraction processes. The aim of the present work was to define appropriate protocol(s) for bone ECM protein extraction that could be applied to investigate both normal and pathological conditions. We compared and optimised some of the most used protocols present in the literature, modifying the protein precipitation method, the buffer used for resuspension and/or the volume of reagent used. Bradford and BCA assays and Western Blotting were used to evaluate the variations in the total protein recovery and the amount of selected proteins (Type I Collagen, TGF-β, IGF-1, Decorin, Osteopontin, Bone Sialoprotein-2 and Osteocalcin). Collectively, we were capable to draw-up two single-extract protocols with optimal recovery and ideal protein content, that can be used for a detailed analysis of ECM proteins in pathological bone samples. Time-consuming multi-extract procedures, optimised in their precipitation methods, are however crucial for a precise detection of specific proteins, like osteocalcin. As the matter of fact, also the demineralization processes, commonly suggested and performed in several protocols, could hinder an accurate protein detection, thus inherently affecting the study of a pathological bone ECM. This study represents a starting point for the definition of appropriate strategies in the study of bone extracellular matrix proteins involved in the onset and maintenance of bone diseases, as well as a tool for the development of customized scaffolds capable to modulate a proper feedback loop in bone remodelling, altered in case of diseases like osteoporosis.
对骨细胞外基质 (ECM) 蛋白质进行精确分析是骨质疏松等骨疾病医学研究的关键。该领域的研究历史上主要是针对动物样本进行的,旨在了解骨生物学,迄今为止,仅有少数关于人类骨中蛋白质检测的研究。骨 ECM 蛋白质提取和定量方法的挑战与蛋白质与矿物质(即羟磷灰石)的分离以及在提取过程中避免蛋白质变性的难度有关。本研究的目的是定义适用于研究正常和病理条件的骨 ECM 蛋白质提取方案。我们比较和优化了文献中一些最常用的方案,修改了蛋白质沉淀方法、用于重悬的缓冲液和/或试剂的体积。Bradford 和 BCA 测定法和 Western Blotting 用于评估总蛋白回收率和选定蛋白质(I 型胶原蛋白、TGF-β、IGF-1、核心蛋白聚糖、骨桥蛋白、骨唾液蛋白-2 和骨钙素)量的变化。总的来说,我们能够制定两种具有最佳回收率和理想蛋白质含量的单一提取方案,可用于对病理性骨样本中 ECM 蛋白质进行详细分析。然而,针对特定蛋白质(如骨钙素)的精确检测,需要耗时的多步提取程序,并对其沉淀方法进行优化。事实上,脱矿质过程通常在多个方案中被建议和执行,也可能会阻碍蛋白质的准确检测,从而影响对病理性骨 ECM 的研究。本研究为定义参与骨疾病发生和维持的骨细胞外基质蛋白质的研究提供了起点,也是开发能够调节骨重塑中适当反馈回路的定制支架的工具,在骨质疏松症等疾病的情况下,该回路会发生改变。